(R)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-2-hydroxy-2-phenylacetamide

Catalog No. :
ACSJLG084
CAS No. :
1684453-05-1
Molecular Formula :
C21H22N4O3S
Molecular Weight :
410.50

IUPAC Name:(R)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-2-hydroxy-2-phenylacetamide

(R)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-2-hydroxy-2-phenylacetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-2-hydroxy-2-phenylacetamide
IUPAC Name(R)-N-(4-(2-(2-aminothiazol-4-yl)acetamido)phenethyl)-2-hydroxy-2-phenylacetamide
Molecular FormulaC21H22N4O3S
Molecular Weight410.50
SMILESNC1=NC(CC(=O)NC2=CC=C(CCNC(=O)[C@H](O)C3=CC=CC=C3)C=C2)=CS1
InChI KeyJJFKDDZCFZVISI-LJQANCHMSA-N
SynonymMirabegron Impurity 36 (2-Oxo Mirabegron);Mirabegron Impurity 36;4-Thiazoleacetamide, 2-amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylacetyl]amino]ethyl]phenyl]-;Mirabegron Impurity B (Mirabegron amide impurity);Mirabegron Impurities16;Mirabegron 2-Oxo Impurity;Mirabegron 2-Oxo Impurity/2-Oxo Mirabegron/2-Amino-N-[4-[2-[[(2R)-2-hydroxy-2-phenylacetyl]amino]ethyl]phenyl]-4-Thiazoleacetamide
CAS No.1684453-05-1

Synthetic Route by SureRoute

1. ACSJLG084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSJLG084 route product structure diagram
    ACSJLG0841684453-05-1
Inquiry

2. ACSJLG084 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSJLG084 route product structure diagram
    ACSJLG0841684453-05-1
Inquiry

Comments (0)